|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bruix J and Sherman M: American
Association for the Study of Liver Diseases: Management of
hepatocellular carcinoma: An update. Hepatology. 53:1020–1022.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hsu CY, Liu PH, Hsia CY, Lee YH, Nagaria
TS, Lee RC, Lin HC and Huo TI: Surgical resection is better than
transarterial chemoembolization for patients with hepatocellular
carcinoma beyond the milan criteria: A prognostic nomogram study.
Ann Surg Oncol. 23:994–1002. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tremosini S, Reig M, de Lope CR, Forner A
and Bruix J: Treatment of early hepatocellular carcinoma: Towards
personalized therapy. Dig Liver Dis. 42 Suppl 3:S242–S248. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Imamura H, Matsuyama Y, Tanaka E, Ohkubo
T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T,
Kawasaki S and Makuuchi M: Risk factors contributing to early and
late phase intrahepatic recurrence of hepatocellular carcinoma
after hepatectomy. J Hepatol. 38:200–207. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lin SL, Chang DC, Ying SY, Leu D and Wu
DT: MicroRNA miR-302 inhibits the tumorigenecity of human
pluripotent stem cells by coordinate suppression of the CDK2 and
CDK4/6 cell cycle pathways. Cancer Res. 70:9473–9482. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Z, Yin B, Wang B, Ma Z, Liu W and Lv
G: MicroRNA-210 promotes proliferation and invasion of peripheral
nerve sheath tumor cells targeting EFNA3. Oncol Res. 21:145–154.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tome M, López-Romero P, Albo C, Sepúlveda
JC, Fernández-Gutiérrez B, Dopazo A, Bernad A and González MA:
miR-335 orchestrates cell proliferation, migration and
differentiation in human mesenchymal stem cells. Cell Death Differ.
18:985–995. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, He X, Liu Y, Ye Y, Zhang H, He P,
Zhang Q, Dong L, Liu Y and Dong J: microRNA-320a inhibits tumor
invasion by targeting neuropilin 1 and is associated with liver
metastasis in colorectal cancer. Oncol Rep. 27:685–694.
2012.PubMed/NCBI
|
|
11
|
Ma D, Tao X, Gao F, Fan C and Wu D:
miR-224 functions as an onco-miRNA in hepatocellular carcinoma
cells by activating AKT signaling. Oncol Lett. 4:483–488. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xu J, Li J, Zheng TH, Bai L and Liu ZJ:
MicroRNAs in the occurrence and development of primary
hepatocellular carcinoma. Adv Clin Exp Med. 25:971–975. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Fei B, Wang Q, Song M, Yin Y,
Zhang B, Ni S, Guo W, Bian Z, Quan C, et al: MicroRNA-638 inhibits
cell proliferation, invasion and regulates cell cycle by targeting
tetraspanin 1 in human colorectal carcinoma. Oncotarget.
5:12083–12096. 2014.PubMed/NCBI
|
|
15
|
Zhang J, Bian Z, Zhou J, Song M, Liu Z,
Feng Y, Zhe L, Zhang B, Yin Y and Huang Z: MicroRNA-638 inhibits
cell proliferation by targeting phospholipase D1 in human gastric
carcinoma. Protein Cell. 6:680–688. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tan X, Peng J, Fu Y, An S, Rezaei K,
Tabbara S, Teal CB, Man YG, Brem RF and Fu SW: miR-638 mediated
regulation of BRCA1 affects DNA repair and sensitivity to UV and
cisplatin in triple-negative breast cancer. Breast Cancer Res.
16:4352014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang XX, Liu J, Tang YM, Hong L, Zeng Z
and Tan GH: MicroRNA-638 inhibits cell proliferation by targeting
suppress PIM1 expression in human osteosarcoma. Tumour Biol. Jan
3–2017.(Epub ahead of print).
|
|
18
|
Bhattacharya A, Schmitz U, Raatz Y,
Schönherr M, Kottek T, Schauer M, Franz S, Saalbach A, Anderegg U,
Wolkenhauer O, et al: miR-638 promotes melanoma metastasis and
protects melanoma cells from apoptosis and autophagy. Oncotarget.
6:2966–2980. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fong H, Hohenstein KA and Donovan PJ:
Regulation of self-renewal and pluripotency by Sox2 in human
embryonic stem cells. Stem cells. 26:1931–1938. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Leis O, Eguiara A, Lopez-Arribillaga E,
Alberdi MJ, Hernandez-Garcia S, Elorriaga K, Pandiella A, Rezola R
and Martin AG: Sox2 expression in breast tumours and activation in
breast cancer stem cells. Oncogene. 31:1354–1365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Neumann J, Bahr F, Horst D, Kriegl L,
Engel J, Luque RM, Gerhard M, Kirchner T and Jung A: SOX2
expression correlates with lymph-node metastases and distant spread
in right-sided colon cancer. BMC Cancer. 11:5182011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jia X, Li X, Xu Y, Zhang S, Mou W, Liu Y,
Liu Y, Lv D, Liu CH, Tan X, et al: SOX2 promotes tumorigenesis and
increases the anti-apoptotic property of human prostate cancer
cell. J Mol Cell Biol. 3:230–238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nakatsugawa M, Takahashi A, Hirohashi Y,
Torigoe T, Inoda S, Murase M, Asanuma H, Tamura Y, Morita R,
Michifuri Y, et al: SOX2 is overexpressed in stem-like cells of
human lung adenocarcinoma and augments the tumorigenicity. Lab
Invest. 91:1796–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Huang Y, Zhu L, Chen M, Huang Y,
Zhang J, He S, Li A, Chen R and Zhou J: SOX2 inhibits metastasis in
gastric cancer. J Cancer Res Clin Oncol. 142:1221–1230. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cho YY, Kim DJ, Lee HS, Jeong CH, Cho EJ,
Kim MO, Byun S, Lee KY, Yao K, Carper A, et al: Autophagy and
cellular senescence mediated by Sox2 suppress malignancy of cancer
cells. PLoS One. 8:e571722013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang S, Tie J, Wang R, Hu F, Gao L, Wang
W, Wang L, Li Z, Hu S, Tang S, et al: SOX2, a predictor of survival
in gastric cancer, inhibits cell proliferation and metastasis by
regulating PTEN. Cancer Lett. 358:210–219. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ma K, Pan X, Fan P, He Y, Gu J, Wang W,
Zhang T, Li Z and Luo X: Loss of miR-638 in vitro promotes cell
invasion and a mesenchymal-like transition by influencing SOX2
expression in colorectal carcinoma cells. Mol Cancer. 13:1182014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xia Y, Wu Y, Liu B, Wang P and Chen Y:
Downregulation of miR-638 promotes invasion and proliferation by
regulating SOX2 and induces EMT in NSCLC. FEBS Lett. 588:2238–2245.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng J, Chen Y, Zhao P, Liu X, Dong J, Li
J, Huang C, Wu R and Lv Y: Downregulation of miRNA-638 promotes
angiogenesis and growth of hepatocellular carcinoma by targeting
VEGF. Oncotarget. 7:30702–30711. 2016.PubMed/NCBI
|
|
30
|
Zhang Y, Zhang D, Jiang J and Dong L: Loss
of miR-638 promotes invasion and epithelial-mesenchymal transition
by targeting SOX2 in hepatocellular carcinoma. Oncol Rep.
37:323–332. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Poon RT and Fan ST: Evaluation of the new
AJCC/UICC staging system for hepatocellular carcinoma after hepatic
resection in Chinese patients. Surg Oncol Clin N Am. 12(35–50):
viii2003.
|
|
32
|
Li ZS and Li Q: The latest 2010 WHO
classification of tumors of digestive system. Zhonghua Bing Li Xue
Za Zhi. 40:351–354. 2011.(In Chinese). PubMed/NCBI
|
|
33
|
Flejou JF: WHO Classification of digestive
tumors: The fourth edition. Ann Pathol. 31 5 Suppl:S27–S31.
2011.PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang X, Wei J, Zhou L, Zhou C, Shi J,
Yuan Q, Yang M and Lin D: A functional BRCA1 coding sequence
genetic variant contributes to risk of esophageal squamous cell
carcinoma. Carcinogenesis. 34:2309–2313. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhao LY, Yao Y, Han J, Yang J, Wang XF,
Tong DD, Song TS, Huang C and Shao Y: miR-638 suppresses cell
proliferation in gastric cancer by targeting Sp2. Dig Dis Sci.
59:1743–1753. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tay Y, Tan SM, Karreth FA, Lieberman J and
Pandolfi PP: Characterization of dual PTEN and p53-targeting
microRNAs identifies microRNA-638/Dnm2 as a two-hit oncogenic
locus. Cell Rep. 8:714–722. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li D, Wang Q, Liu C, Duan H, Zeng X, Zhang
B, Li X, Zhao J, Tang S, Li Z, et al: Aberrant expression of
miR-638 contributes to benzo(a)pyrene-induced human cell
transformation. Toxicol Sci. 125:382–391. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wegner M: From head to toes: The multiple
facets of Sox proteins. Nucleic Acids Res. 27:1409–1420. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ishii Y, Rex M, Scotting PJ and Yasugi S:
Region-specific expression of chicken Sox2 in the developing gut
and lung epithelium: Regulation by epithelial-mesenchymal
interactions. Dev Dyn. 213:464–475. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liu K, Lin B, Zhao M, Yang X, Chen M, Gao
A, Liu F, Que J and Lan X: The multiple roles for Sox2 in stem cell
maintenance and tumorigenesis. Cell Signal. 25:1264–1271. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Honing J, Pavlov KV, Meijer C, Smit JK,
Boersma-van Ek W, Karrenbeld A, Burgerhof JG, Kruyt FA and Plukker
JT: Loss of CD44 and SOX2 expression is correlated with a poor
prognosis in esophageal adenocarcinoma patients. Ann Surg Oncol. 21
Suppl 4:S657–S664. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lundberg IV, Löfgren Burström A, Edin S,
Eklöf V, Öberg Å, Stenling R, Palmqvist R and Wikberg ML: SOX2
expression is regulated by BRAF and contributes to poor patient
prognosis in colorectal cancer. PLoS One. 9:e1019572014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li J, Du L, Yang Y, Wang C, Liu H, Wang L,
Zhang X, Li W, Zheng G and Dong Z: MiR-429 is an independent
prognostic factor in colorectal cancer and exerts its
anti-apoptotic function by targeting SOX2. Cancer Lett. 329:84–90.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Otsubo T, Akiyama Y, Hashimoto Y, Shimada
S, Goto K and Yuasa Y: MicroRNA-126 inhibits SOX2 expression and
contributes to gastric carcinogenesis. PLoS One. 6:e166172011.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Z, Qiao Q, Chen M, Li X, Wang Z, Liu
C and Xie Z: miR-625 down-regulation promotes proliferation and
invasion in esophageal cancer by targeting Sox2. FEBS Lett.
588:915–921. 2014. View Article : Google Scholar : PubMed/NCBI
|
